Healthcare Organization Nathealth Welcomes Prime Minister's Announcement Regarding GST Reforms; Advocates for Unified GST Rate at 5% and Input Tax Credits in the Healthcare Sector
Agilus Diagnostics, a renowned name in the diagnostic arena, has launched a new diagnostic center in Kuvempunagar, Mysuru, Karnataka. This new facility, a joint venture between Agilus Diagnostics and the Karnataka CDC, is equipped with state-of-the-art technology for accurate and efficient testing.
The launch of the new diagnostic center is a significant step in the healthcare sector in Mysuru, expected to enhance diagnostic services in the region. Upendra Singh, the managing director of Agilus Diagnostics, oversees this collaboration.
In a separate development, the World Health Organization (WHO) has added rapid-acting insulin analogues and GLP-1 receptor agonists to the Essential Medicines List (EML). These additions are expected to improve diabetes management globally.
Meanwhile, in the realm of robotics, there is ongoing discussion about its role in kidney-preserving cancer care. However, no new standalone facts were provided in the current context.
Elsewhere, the Department for Promotion of Industry and Internal Trade (DPIIT) has signed an MoU with Pfizer to accelerate the lab-to-market journey of healthcare products. This collaboration aims to boost the Indian healthcare sector and improve access to quality healthcare for all.
Agilus Diagnostics, with its precision-AI technology, is at the forefront of delivering diagnostics at scale in the healthcare sector. The new diagnostic center in Mysuru is yet another testament to their commitment to advancing healthcare technology and services.
ShardaCare Healthcity and Sharda Hospital have announced the appointment of Sandeep Dogra as Group COO. This move is expected to strengthen their management structure and drive growth in their operations.
In conclusion, the healthcare sector in Mysuru is witnessing a transformation with the launch of the new diagnostic center by Agilus Diagnostics. The addition of these essential medicines to the EML by the WHO and collaborations like the one between DPIIT and Pfizer are further steps towards improving healthcare services and accessibility.
Read also:
- Peptide YY (PYY): Exploring its Role in Appetite Suppression, Intestinal Health, and Cognitive Links
- Toddler Health: Rotavirus Signs, Origins, and Potential Complications
- Digestive issues and heart discomfort: Root causes and associated health conditions
- House Infernos: Deadly Hazards Surpassing the Flames